Quick Answer
FRACTYL HEALTH, INC. reported Net Income of -$140.95 million for fiscal year 2025.
FRACTYL HEALTH, INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net Income | -$140.95M -105.2% |
-$68.69M +10.9% |
-$77.09M | — |
| Diluted EPS | -$1.86 -14.8% |
-$1.62 +96.4% |
-$45.29 | — |
| Total Assets | $121.40M +12.3% |
$108.08M +41.8% |
$76.21M | — |
| Cash and Equivalents | $81.54M +20.9% |
$67.46M +103.1% |
$33.21M | — |
| Stockholders Equity | $9.46M -66.7% |
$28.42M +108.7% |
-$325.06M -28.8% |
-$252.32M |
| R&D Expense | $74.54M +5.8% |
$70.47M +85.3% |
$38.04M | — |
| Operating Income | -$96.82M -3.5% |
-$93.53M -84.0% |
-$50.84M | — |
| Gross Profit | — | $43.0K +0.0% |
$43.0K | — |
| Shares Outstanding | 153.37M +214.6% |
48.76M +2215.3% |
2.11M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | -$45.60M | -96.8% | -63.5% |
| Diluted EPS | September 30, 2025 | -$0.71 | -47.9% | -24.6% |
| Total Assets | September 30, 2025 | $114.27M | -10.0% | +84.3% |
| Cash and Equivalents | September 30, 2025 | $77.66M | -8.3% | +248.4% |
| Stockholders Equity | September 30, 2025 | -$3.18M | -106.3% | +82.5% |
| R&D Expense | September 30, 2025 | $17.46M | -8.1% | -17.5% |
| Operating Income | September 30, 2025 | -$22.69M | +4.6% | +13.0% |
| Gross Profit | September 30, 2024 | $7.0K | -36.4% | -63.2% |
| Shares Outstanding | September 30, 2025 | 132.22M | +174.9% | +164.9% |
- FRACTYL HEALTH, INC. reported Net Income of -$140.95 million for fiscal year 2025.
- FRACTYL HEALTH, INC. showed a decrease of -105.2% in Net Income compared to the prior fiscal year.
- FRACTYL HEALTH, INC. reported Diluted EPS of $1.86 per share (loss) for fiscal year 2025.
- FRACTYL HEALTH, INC. showed a decrease of -14.8% in Diluted EPS compared to the prior fiscal year.
- FRACTYL HEALTH, INC. reported Total Assets of $121.40 million for fiscal year 2025.
- FRACTYL HEALTH, INC. showed an increase of +12.3% in Total Assets compared to the prior fiscal year.
- FRACTYL HEALTH, INC. reported Cash and Equivalents of $81.54 million for fiscal year 2025.
- FRACTYL HEALTH, INC. showed an increase of +20.9% in Cash and Equivalents compared to the prior fiscal year.
- FRACTYL HEALTH, INC. reported Stockholders Equity of $9.46 million for fiscal year 2025.
- FRACTYL HEALTH, INC. showed a decrease of -66.7% in Stockholders Equity compared to the prior fiscal year.
- FRACTYL HEALTH, INC. reported R&D Expense of $74.54 million for fiscal year 2025.
- FRACTYL HEALTH, INC. showed an increase of +5.8% in R&D Expense compared to the prior fiscal year.
- FRACTYL HEALTH, INC. reported Operating Income of -$96.82 million for fiscal year 2025.
- FRACTYL HEALTH, INC. showed a decrease of -3.5% in Operating Income compared to the prior fiscal year.
- FRACTYL HEALTH, INC. reported Gross Profit of $43.0 thousand for fiscal year 2024.
- FRACTYL HEALTH, INC. showed an increase of +0.0% in Gross Profit compared to the prior fiscal year.
- FRACTYL HEALTH, INC. reported Shares Outstanding of 153.37 million shares for fiscal year 2025.
- FRACTYL HEALTH, INC. showed an increase of +214.6% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: